Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir for Genital HSV Shedding
NCT01448616Phase 4Completed
- Sponsor
- University of Washington
- Start
- Feb 2012
- Primary completion
- Jun 2015
- Modality
- Implantable Devices, Transdermal Patches, Hydrogel Systems
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir gel in herpes simplex virus type 2 infection, sponsored by University of Washington. Started Feb 2012; status: completed.
02
Drugs
tenofovir gel
03
Conditions
herpes simplex virus type 2 infection
Beyond the preview
Go deeper on NCT01448616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448616.